Colorimetric immunoassay process
Quantitative and qualitative measurement of antigenic materials present in blood serum or other biological fluids or cells is effected by an extremely precise and sensitive colorimetric immunoassay process. This process …
Original patent title: “Colorimetric immunoassay process”
What this patent covers
The actual claim
Quantitative and qualitative measurement of antigenic materials present in blood serum or other biological fluids or cells is effected by an extremely precise and sensitive colorimetric immunoassay process. This process comprises adding to the sample to be tested a colorimetric immunoassay agent which comprises an adduct of (1) an antibody for the antigen to be tested and (2) a chromoprotein which is capable of chemically coupling to the antibody by covalent bonding and which chromoprotein imparts to the adduct a characteristic absorbance spectrum in the visible light wavelength range. After reacting this colorimetric immunoassay agent with the antigen to form a reagent-antigen complex, either in the complex-containing fraction or a fraction containing unreacted reagent can be analyzed using standard colorimetric equipment and procedures to provide a fast, simple and direct measurement of the antigen concentration in the sample.
What this patent does NOT cover
The boundaries
These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.
Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.
Patent Abstract
Patent abstract
Quantitative and qualitative measurement of antigenic materials present in blood serum or other biological fluids or cells is effected by an extremely precise and sensitive colorimetric immunoassay process. This process comprises adding to the sample to be tested a colorimetric immunoassay agent which comprises an adduct of (1) an antibody for the antigen to be tested and (2) a chromoprotein which is capable of chemically coupling to the antibody by covalent bonding and which chromoprotein imparts to the adduct a characteristic absorbance spectrum in the visible light wavelength range. After reacting this colorimetric immunoassay agent with the antigen to form a reagent-antigen complex, either in the complex-containing fraction or a fraction containing unreacted reagent can be analyzed using standard colorimetric equipment and procedures to provide a fast, simple and direct measurement of the antigen concentration in the sample.
Patent Journey
From filing to expiry
Patent Filed
1978
Patent Granted
1981 · 3yr after filing
Patent Expired
1998
PatentBrief Score
Impact Score
Early stage
Citation count
29/40
Moderately cited
Claim breadth
9/20
Moderate scope
Recency
0/20
Older than 20 years
Assignee scale
0/20
Independent or smaller assignee
PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.
The original legal language
Original claims
14 claims as filed with the patent office.
Citations
Patent lineage
Stay in the loop
Get a weekly digest of new patents.
One email per week. No spam. Unsubscribe anytime.
Keep exploring
Related patents you should know
US 12564871 · 2026
A Fixture for Cleaning Showerheads with Multiple Separate Chambers
This patent describes a cleaning device for showerheads that uses a fixture with three or more separate internal compartments and channels to direct cleaning fluid to the showerhead's upper surfaces.
ASM IP HOLDING BV
US 12324579 · 2025
Surgical Stapler Battery Health Check During Operation
This patent describes a powered surgical stapler that can detect if some of its rechargeable battery cells are damaged while it's actually firing staples, helping ensure the procedure finishes safely.
CILAG GMBH INT
US 12471982 · 2025
Surgical Tool That Combines Energy Treatment and Stapling
CILAG's patent details a surgical instrument that applies therapeutic energy to tissue, monitors its properties, then deploys staples, adapting the stapling based on the initial energy treatment and monitoring.
CILAG GMBH INT
US 11918209 · 2024
Real-Time Surgical Instrument Status on Live Video During Operations
This patent describes a surgical system that shows live video from inside the body and overlays important information about the surgical tool directly onto the screen, helping surgeons operate more precisely.
CILAG GMBH INT
US 8697359 · 2014
How to Use CRISPR-Cas9 to Edit Genes in Human Cells
This patent describes a method and system for precisely altering gene expression in eukaryotic cells, including human cells, using an engineered CRISPR-Cas9 system that targets and cleaves specific DNA sequences.
Massachusetts Institute of Technology
US 4683195 · 1987
How to Make Many Copies of a Specific DNA Segment
This patent describes the Polymerase Chain Reaction (PCR), a fundamental process for making millions of copies of a specific DNA or RNA segment from a tiny sample, enabling its detection.
Cetus Corp
Same assignee
More from Individual
Patent monitoring